PCV157 COST-EFFECTIVENESS OF RIVAROXABAN 2.5 MG BID WITH ASA VERSUS ASA MONOTHERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE OR PERIPHERAL ARTERY DISEASE IN SLOVAKIA

PCV157 COST-EFFECTIVENESS OF RIVAROXABAN 2.5 MG BID WITH ASA VERSUS ASA MONOTHERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE OR PERIPHERAL ARTERY DISEASE IN SLOVAKIA

2019 Value in Health

Psota, M. | Psenkova, M. | Briere, J.B. | Bowrin, K. | Millier, A. | Paulis, L. | Krockova, R. | Volume: 22, Issue: , Pages: S571,